<p><strong>Eliquis Market</strong> Size, Share, Trends, Scope, Statistics, <strong>By Indication / Application</strong>&nbsp;(Non-valvular Atrial Fibrillation (NVAF) &ndash; stroke/systemic embolism prevention, Deep Vein Thrombosis (DVT) treatment/prevention, Pulmonary Embolism (PE) treatment/prevention, Post-operative VTE prophylaxis (e.g., hip/knee replacement)),&nbsp;<strong>By Strength / Dosage</strong>&nbsp;(5 mg tablets, 2.5 mg tablets),&nbsp;<strong>By Distribution Channel</strong>&nbsp;(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Mail-Order Pharmacies),&nbsp;<strong>By Payer / Pricing Model</strong>&nbsp;(Insured/reimbursed (commercial/Medicare), Direct-to-consumer (cash/discount programs)),&nbsp;<strong>By Region</strong>&nbsp;(North America (especially the U.S.), Europe, Asia Pacific, Latin America, Middle East &amp; Africa (MEA)), Industry Forecast <strong>(2025-2032)</strong></p>

Eliquis Market Size to Hit USD 28.92 Billion by 2032